APA (7th ed.) Citation

Pissa, M., Helkkula, T., Appelqvist, F., Silander, G., Borg, Å., Pettersson, J., . . . Helgadottir, H. (2021). CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: Implications for novel national recommendations. Acta Oncologica, 60(7), 888. https://doi.org/10.1080/0284186X.2021.1914346

Chicago Style (17th ed.) Citation

Pissa, Maria, et al. "CDKN2A Genetic Testing in Melanoma-prone Families in Sweden in the Years 2015–2020: Implications for Novel National Recommendations." Acta Oncologica 60, no. 7 (2021): 888. https://doi.org/10.1080/0284186X.2021.1914346.

MLA (9th ed.) Citation

Pissa, Maria, et al. "CDKN2A Genetic Testing in Melanoma-prone Families in Sweden in the Years 2015–2020: Implications for Novel National Recommendations." Acta Oncologica, vol. 60, no. 7, 2021, p. 888, https://doi.org/10.1080/0284186X.2021.1914346.